LANXESS - Q1 2019 Conference Presentation - Stable performance despite weakening economy
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
LANXESS – Q1 2019 Conference Presentation Stable performance despite weakening economy Investor Relations
Safe harbor statement The information included in this presentation is being provided for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to purchase, securities of LANXESS AG. No public market exists for the securities of LANXESS AG in the United States. This presentation contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward- looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document. 2
Q1 2019: Resilience proven again EBITDA pre [€ m] EPS pre [€] +2% +10% 270 275 1.16 1.28 Q1 2018 Q1 2019 Q1 2018 Q1 2019 EBITDA pre margin Net financial debt [€ m] +20bp +21% 14.9% 15.1% 1,675 1,381 Q1 2018 Q1 2019 Q4 2018 Q1 2019 4
More diversified and resilient end market exposure and… End market split by sales Others 15% 20% Construction, E&E, 15% Leather 20% Agro Chemicals 10% 15% 10% Chemicals 30% Automotive 45% 20% 2014 2018 5
…substantially reduced dependency on volatile raw materials LANXESS global raw materials index* Total raw material expenses (2018) 1,3-Butadiene 200 Isobutylene Cyclohexane 180 Toluene 160 Raffinate I Ethylene 140 Ammonia 120 Propylene Styrene 100 Chlorine 80 Cyclohexanon Acrylonitrile 60 Benzene 40 4-ADPA Aniline 20 0 LANXESS no longer dependent on few raw materials * Average 2013 = 100% 6
LANXESS with track record of organic growth… Visible organic EBITDA pre growth in all segments LANXESS EBITDA pre* [€ m] CAGR CAGR [€ m] ~4% ~8% CAGR ~8% Adv. Spec. Intermed. Add. 2014 LTM 2019 2014 LTM 2019 CAGR CAGR ~2% ~23% Perf. Eng. Chem. Mat. 2014 Consensus 2019 2014 LTM 2019 2014 LTM 2019 Organic growth Portfolio effect 7 * LANXESS without ARLANXEO
…and EBITDA-margin in targeted corridor Trajectory to mid-term target [EBITDA pre margin] 18% Ø14-18%* 14.1% 14% 12.9% 13.3% 11.2% 10.1% 10% 8.9% 6% 2013 2013 2014 2014 2015 2015 2016 2016 2017 2017 2018 2018 […] 2021 onwards Figures until 2017 incl. ARLANXEO 8 * Group EBITDA pre margin through the cycle
Sustainability as core element of our strategy Corporate Responsibility – Material topics and goals* LANXESS: Leading, stable, sustainable and profitable Climate Motivated Safe and Business- Sustainable Valuing Resilient protection and employees and sustainable driven product customer sourcing energy performing sites innovation portfolio relations efficiency teams Good Corporate Governance Permanently Reduction of -25% Energy Keeping increase the 20% women in occupational consumption customer proportion of management accidents by and emissions loyalty at a evaluated by 2020 >50% by 2025 until 2025** high level suppliers * Selection from all goals shown ** Specific emissions, base year 2015 9
Improving portfolio of businesses Organic growth Portfolio management Several projects of manageable size underway Acquisitions executed at reasonable prices strengthen portfolio and add resilience Attractive, return-improving project ROCE (~20%) Divestments prove diligent approach to portfolio management 10
Continuous enhancement of business set-up Restructuring Synergies Site closures where restructuring is necessary Realization of Chemtura synergies ahead of plan Continuous evaluation of businesses Sales synergies not included, providing further cushion in softening environment Solid foundation for the LANXESS platform 11
Self-help measures in place to achieve goals Self-help measures On track to reach financial goals for 2021 Debottlenecking and brownfield growth EBITDA pre capex (ROCE of ~20%) Implementation of remaining €30 m margin (group, Ø through 14-18% the cycle) synergies from Chemtura until 2020 Saltigo improvement Cash con- Take Organometallics' margin to industry version* >60% level (~15%) Further portfolio alignment EBITDA pre margin volatility L2-3%pts OW 12 * Cash conversion: (EBITDA pre – capex) / EBITDA pre
Agenda 1 Resilient in challenging times 2 Q1 – a solid start to 2019 3 Back-up 13
Q1 2019: EBITDA pre robust despite economic headwinds Highlights Challenges EBITDA pre (€275 m) 2% above strong Volume decline due to softer end markets (e.g. previous year automotive industry) and termination of low margin contracts and site closures (ADD) EBITDA pre margin increase to 15.1% Further increase of freight and energy prices €111 m* of €200 m share buy-back program already executed Three out of four segments with improved performance 14 * Status 31 March 2019
Q1 2019: Again evidence of resilience 1 [€ m] Q1 2018 Q1 2019 yoy in % Stable sales: positive pricing and Sales 1,816 1,822 0% FX effect offset by lower volumes EBITDA pre and margin reflect EBITDA pre 270 275 2% successful pricing and favorable margin 14.9% 15.1% FX, partly offset by lower volumes and higher energy and freight costs EPS 0.89 0.93 4% Share buy-back supports EPS EPS pre 2 1.16 1.28 10% increase Higher capex resulting from Capex 60 72 20% investments in debottleneckings Net debt impacted by ongoing 4 share buy-back (~€111 m) and [€ m] 2 31.12.2018 31.03.2019 Δ% IFRS 16 effect (~€130 m) Seasonally higher working capital Net financial debt 3 1,381 1,675 21% Net working capital 1,455 1,636 12% 1 2018 applies to continuing operations 4 Status 31 March 2019 15 2 Net of exceptionals and amortization of intangible assets as well as attributable tax effects 3 After deduction of time deposits and securities available for sale
Q1 2019: Positive price and FX mitigated by lower volumes Q1 yoy sales variances Price Volume FX Portfolio Total Stable sales: Price increase and positive FX Advanced Intermediates 0% +1% +2% 0% +4% effect offset by lower volumes in BUs with auto exposure Specialty Additives +1% -9% +5% +1% -3% Performance Chemicals 0% 0% +4% 0% +3% Engineering Materials +1% -6% +3% 0% -3% LANXESS +1% -4% +3% 0% 0% Q1 yoy LANXESS EBITDA pre bridge [€ m] EBITDA pre increases as lower volumes are offset by positive FX and pricing effects 270 275 “Other“ include IFRS 16 and FX effects Q1 2018 Volume Price Input costs Other Q1 2019 16
Q1 2019: Advanced Intermediates very strong; Specialty Additives again with improved margins Advanced Intermediates Specialty Additives Price Volume FX Portfolio Price Volume FX Portfolio +0% +1% +2% 0% +1% -9% +5% +1% Total +4% Total -3% Solid volume growth with improved product mix in BU Sales decline driven by lower volumes AII and in BU SGO despite still weak agro market Volume drop due to termination of margin-dilutive Considerably improved EBITDA pre and margin versus tolling agreements, closure of sites and lower auto already high previous-year level due to recovering BU demand (especially BU RCH) SGO and strong performance in BU AII Portfolio reflects Solvay’s U.S. phosphorus additives Rising EBITDA pre and margin driven by pricing, FX and synergies [€ m] Q1'18 Q1'19 [€ m] Q1'18 Q1'19 Sales 565 586 Sales 500 485 EBITDA pre 102 114 EBITDA pre 81 83 Margin 18.1% 19.5% Margin 16.2% 17.1% 17
Q1 2019: Performance Chemicals stabilizing, Engineering Materials softer due to lower auto demand Performance Chemicals Engineering Materials Price Volume FX Portfolio Price Volume FX Portfolio 0% 0% +4% 0% +1% -6% +3% 0% Total +3% Total -3% Higher sales driven by positive currency effects Sales decline resulting from lower volumes, mitigated Price increases in BU MPP and BU LPT offset by slightly by USD tailwind and pricing lower prices in BU IPG and BU LEA Lower volumes mainly in BU HPM due to weaker auto demand Improved volumes in all BUs Text but LEA due to strikes EBITDA pre burdened by volumes despite favorable EBITDA pre and margin reflect good performance of BUs pricing and FX Text MPP and LPT and positive FX Margin remains on good level despite end market weakness [€ m] Q1'18 Q1'19 [€ m] Q1'18 Q1'19 Sales 336 347 Sales 392 382 EBITDA pre 52 54 EBITDA pre 73 65 Margin 15.5% 15.6% Margin 18.6% 17.0% 18
Q1 2019: Solid performance on high comparable base 1 [€ m] Q1 2018 Q1 2019 yoy in % Increase in selling expenses driven by higher freight costs Sales 1,816 (100%) 1,822 (100%) 0% Reduced G&A costs due to lower Cost of sales -1,342 (-74%) -1,351 (-74%) -1% provisions for var. compensation Selling -199 (-11%) -216 (-12%) -9% and lower costs of the former G&A -77 (-4%) -66 (-4%) 14% Chemtura businesses Improved net income driven by R&D -30 (-2%) -28 (-2%) 7% better financial result and tax rate EBIT 154 (8%) 139 (8%) -10% Increased EPS pre also reflects Net Income 81 (4%) 84 (5%) 4% share buy-back 2 EPS pre 1.16 1.28 10% Higher exceptionals due to M&A projects, adjustment of production EBITDA 255 (14%) 253 (14%) -1% network and digitalization thereof exceptionals -15 (-1%) -22 (-1%) 47% EBITDA pre exceptionals 270 (14.9%) 275 (15.1%) 2% Figures reflect higher resilience 1) 2018 applies to continuing operations 19 2) Net of exceptionals and amortization of intangible assets as well as attributable tax effects
Proven stability of portfolio – EBITDA pre decline in Engineering Materials offset by other segments [€ m] Q1 2019 Sales [€ m] Q1 2019 EBITDA pre +2% +0% AII SGO 270 275 1,816* 1,822* 102 114 +12% Advanced 565 +4% 586 ADD RCH Intermediates 81 +2% 83 Specialty 500 -3% 485 Additives IPG LEA MPP LPT 52 +4% 54 Performance 336 +3% 347 Chemicals Engineering 392 -3% 382 HPM URE 73 -11% 65 Materials Q1 2018 Q1 2019 -38 -41 Q1 2018 Q1 2019 Advanced Intermediates Specialty Additives Performance Chemicals Engineering Materials Reconciliation * Total group sales including reconciliation 20
Q1 2019: FX driven sales growth in Americas and Asia offset by decline in EMEA and Germany Q1 2019 sales by region [%] Regional development of sales [€ m] Operational 1,816 1,822 development* North America LatAm Asia/Pacific 391 +2% 399 -3% 5 22 Asia/ LatAm 89 +3% 91 -4% Pacific 22 North America 373 +6% 396 -3% 603 -2% 591 -3% 19 EMEA 32 (excl. Germany) EMEA Germany Germany 360 -4% 345 -5% (excl. Germany) Q1 '18 Q1 '19 * Currency and portfolio adjusted 21
Cash flow Q1 2019: Stable operating cash flow 1 [€ m] Q1 2018 Q1 2019 Higher depreciation due to IFRS 16 effect Profit before tax 120 118 Changes in other assets and Depreciation & amortization 101 114 liabilities driven by lower provisions for variable Financial (gain) losses 17 15 compensation and utilization of Income taxes paid -31 -39 provisions, e.g. restructuring Changes in other assets and liabilities 27 -14 Changes in working capital reflects normal seasonal pattern Operating cash flow before changes in WC 234 194 Investing cash flow comprises Changes in working capital -206 -162 investment of liquidity after ARLANXEO divestment Operating cash flow 28 32 Capex increase driven by Investing cash flow -113 -239 debottlenecking investment program Thereof capex -60 -72 Share buy-back reflected in Financing cash flow 11 -157 financing CF 1 2018 applies to continuing operations 22
Balance Sheet: Solid! 1 [€ m] * 31.12.2018 31.03.2019 Stable total assets and equity ratio Total assets 8,687 8,837 Net debt impacted by ongoing Equity (incl. non-controlling interest) 2,773 2,813 share buy-back (€111 m)3and IFRS 16 effect (~€130 m) Equity ratio 32% 32% Cash proceeds from sale of 50% share in ARLANXEO partly Net financial debt 1,381 1,675 included in treasury financial (including cash and near cash assets) assets Near cash, cash & cash equivalents 797 434 Higher pension provisions due to Pension provisions 1,083 1,110 declining underlying interest rate in Germany Net working capital 1,455 1,636 Seasonal increase in net working capital 1 DSI (in days) 69 69 2 DSO (in days) 46 48 1 Days of sales in inventory calculated from quarterly sales 23 2 Days of sales outstanding calculated from quarterly sales 3 Status 31 March 2019
Stable and solid balance sheet [€ [€ m] m] Dec 2018 Mar 2019 Dec 2018 Mar 2019 Non-current assets 4,786 4,977 Stockholders' equity 2,773 2,813 Intangible assets 1,764 1,786 attrib. to non-contr. interests -7 -8 Property, plant & equipment 2,577 2,717 Non-current liabilities 4,395 4,546 Equity investments 0 0 Pension & post empl. provis. 1,083 1,110 Other investments 2 2 Other provisions 337 351 Other financial assets 25 25 Other financial liabilities 2,686 2,783 Tax receivables 14 14 Tax liabilities 117 129 Other non-current assets 404 433 Other liabilities 83 79 Current assets 3,901 3,860 Deferred taxes 89 94 Inventories 1,347 1,386 Current liabilities 1,519 1,478 Trade account receivables 903 975 Other provisions 465 479 Other current financial assets 598 789 Other financial liabilities 59 78 Other current assets 256 276 Trade accounts payable 795 725 Near cash assets 0 0 Tax liabilities 44 48 Cash and cash equivalents 797 434 Other liabilities 156 148 Total assets 8,687 8,837 Total equity & liabilities 8,687 8,837 IFRS 16 effect of ~€130 m impacts PP&E and other financial liabilities 24
FY 2019 EBITDA pre guidance between €1,000 m and €1,050 m General trading environment softer, but not deteriorating Current view Auto: Expected to remain weak, especially in Asia on economy Agro: Recovery not yet visible China: No impulse from governmental stimuli yet FY 2019 EBITDA pre expected LANXESS between €1,000 m and €1,050 m FY 2019 25
Agenda 1 Resilient in challenging times 2 Q1 – a solid start to 2019 3 Back-up 26
Housekeeping items LANXESS financial expectations Capex 2019: ~€500 m Operational D&A 2019: ~€450 m Reconciliation 2019: ~€150 m - €160 m including remnant costs Tax rate: Around 30% Exceptionals 2019: €30 m - €60 m based on current initiatives FX sensitivity: one cent change of USD/EUR resulting in ~€7 m EBITDA pre impact before hedging IFRS 16 effects 2019: Reclassification of ~€35 m from operating result to depreciation and interest expense (low single-digit € millions) leading to EBITDA pre improvement Rise in fair value of leasing liabilities by ~€130 m burdening net debt 27
FY 2018: Improved results in three segments drive performance in tougher environment EBITDA pre Strong performance despite Advanced Agro weakness 335 359 +7% Intermediates Organometallics not being fixed yet 2017 2018 Substantial increase despite Specialty 343 Synergies not yet fully realized +28% Additives 267 Weakness in BU RCH 2017 2018 Very tough chrome ore value chain Performance Difficult market in relevant construction applications 252 -26% Chemicals 187 2017 2018 Significant development despite Engineering 267 Softening demand in auto industry 219 +22% Materials Raw material price headwind in BU URE (TDI / MDI) 2017 2018 28
EBITDA pre and margin continuously improve [€ m] EBITDA pre and margin development first quarter* Q1 EBITDA pre and margin continue to grow Improvement - even in more 20.0% 300 challenging environment - reflects increasing resilience of 250 15.0% LANXESS‘ business setup 200 Q1 2017 margin development held back by lagging raw 10.0% 150 material price pass-through 100 Significant increase in Q1 2018 5.0% due to acquisition of Chemtura 50 and synergies 0.0% 0 Q1 13 Q1 14 Q1 15 Q1 16 Q1 17 Q1 18 Q1 19 EBITDA pre EBITDA pre Margin * LANXESS without ARLANXEO, figures 2013 – 2016 indicative / unaudited 29
LANXESS EBITDA pre increases versus strong prior year despite challenging environment EBITDA pre Q1 2018 vs. Q1 2019 [€ m] 2% Peer A 2% Peer B -2% Peer C -3% Peer D -3% Peer F -11% Peer E -12% Peer G -31% -31% Peer H -58% 30
New Board member responsible for additives business Anno Borkowsky Responsibility for all businesses in the Specialty Additives segment New position underpins importance of additives business at LANXESS Start on June 1, 2019 Roughly 30 years of experience in the chemical industry − Since 1990: working at Bayer / LANXESS − 2004-2017: Head of RheinChemie (additives) business unit − 2017-2019 Head of Additives business unit 31
Reorganization of Specialty Additives segment Advanced Specialty Performance Engineering Intermediates Additives Chemicals Materials Advanced Industrial Polymer Additives (new) Material Protection Products High Performance Materials Intermediates − Flame retardants / other plastics additives Inorganic Pigments Urethane Systems Saltigo − Head of BU: Karsten Job Leather Lubricant Additives Liquid Purification Business (new) Technologies − Lubricants / lubricant additives − Head of BU: Martin Saewe Rhein Chemie − Rubber additives / colorants − Head of BU: Philipp Junge 32
Advanced Intermediates: Solid backbone with focus on organic growth AII SGO Market positions1 TOP 3 #1 Expected growth ~3-4% Recovery in 2019 Development Rather organic Organic & External focus Invest €100 m into Best prepared for agro debottleneckings recovery Ramp up profitability of Expand fine chemicals Growth drivers Organometallics to peer business level (around 15%) 1) Position in global market (LANXESS internal market analysis) 33 Growth assumption on existing asset base
Specialty Additives: Leading additives platform with broad expansion opportunities ADD RCH Market positions1 TOP 3 #1 Expected growth ~4% ~3% Development Organic & External Organic & External focus Generate synergies until Use unique global scale 2020 to penetrate market Leverage position in Leverage innovations Growth drivers dynamic markets Streamline product Push product innovations portfolio (next generation FR) and synthetic base lubricants 1) Position in global market (LANXESS internal market analysis) 34 Growth assumption on existing asset base
Performance Chemicals: Expect structural changes! IPG LEA MPP LPT Market positions1 #1 TOP 2 TOP 3 TOP 3 Expected growth ~ 2% 1 - 2% 3% 4 - 10% Development Organic Restructuring Organic & external Organic & External focus Benefit from industry Trimmed chrome Expand and enrich Option to build-up consolidation value chain regulatory production footprint organization to (new assets) in North Further penetrate and Potential partnerships penetrate global America or China Growth drivers develop North markets American market Further develop Benefit from high-value market disinfection trends applications 1) Position in global market (LANXESS internal market analysis) 35 Growth assumption on existing asset base
Engineering Materials: Leading players with clear strategy for market independent growth HPM URE Market positions1 # 2 Europe #1 Expected growth ~5% ~3% Development Organic Organic & external focus Lightweight trend and Expand market share in e-mobility Europe and Asia Capital light compounding Leverage further product Growth drivers investments innovations (esp. on low-free isocyanate Continuous consumer products) product innovation in E&E Benefit from automation trends 1) Position in global market (LANXESS internal market analysis) 36 Growth assumption on existing asset base
LANXESS delivers on organic growth – upcoming capacity expansions Organic investment program well on track Capex BU AII: Expansion of hexandiol production, Krefeld-Uerdingen (Germany) not discl. Menthol expansion, Krefeld-Uerdingen (Germany) not discl. Expansion for benzyl alcohol, Krefeld-Uerdingen (Germany) small double-digit €m BU RCH: Capacity expansion for Macrolex brand dyes, Leverkusen ~€5m (Germany), available Q2 2019 BU LPT: Ion exchange resigns production, Leverkusen (Germany), single-digit €m available mid 2019 BU IPG: Planned capacity increase for iron oxides pigments, Krefeld- not discl. Uerdingen (Germany) and Porto Feliz (Brazil), available in 2019 BU HPM: New compounding facility in Changzhou (China), available Q2 2019 ~€20m New compounding facility, Krefeld-Uerdingen (Germany) mid double-digit €m Capacity expansion for continuous fiber-reinforced thermoplastic single-digit €m composites at Bond-Laminates, Brilon (Germany), available Q3 2019 BU URE: Additional prepolymers capacity, Porto Feliz (Brazil), available mid 2019 single-digit €m 37
Capital allocation priorities after ARL exit: Focus on deleveraging and building a superior growth platform Capital allocation after receipt of cash Attractive growth Deleveraging Share buy-back M&A following our communicated Funding of German pension liabilities Share buy-back to be executed financial matrix between January and year end 2019 New funding ratio improved to ~57%* Investments into new and already announced brownfield & debottlenecking projects (until ~2021) €400 – €X m €200 m of ~ €400 m - €500 m up to €200 m Use of proceeds in line with investment grade commitment 38 * based on pensions at 31st of December 2018
Chemtura synergies realized ahead of plan Implementation of synergies faster than predicted Key Messages Synergies confirmed − €100 m of “hard” costs [€ m] 2017 2018 2019 2020 Total − Earlier realization Synergies ~30 ~40 ~20 ~10 ~100 − Topline synergies not included ~10 OTCs and cash-outs confirmed Expense (one-time costs)* ~80 ~30 ~20 ~10 ~ 140 Capex confirmed, mainly related to Manufacturing Cash Cashout* out ~40 ~50 ~40 ~10 ~ 140 Excellence Capex ~20 ~20 ~10 ~50 * Does not include ~€65 m PPA charges from inventory step-up in opening balance sheet. Transaction related charges were recognized in opening balance 39 sheet
Business Unit Additives with strong focus on high value-add industrial lubricant solutions Well diversified and specialized lubricants portfolio A leading specialties player Sales of Business Unit Additives - illustrative Commodities Highly diversified end-market ~20% split with focus on industrial lubricants Bromine Strong expertise in high Solutions Auto- value-add specialty lubricants Lubricant motive Leading positions in mid-sized Additives General and niche markets Plastic Industry Additives Automotive exposure well balanced with additives and base stocks only for high Specialities grade specialty engine oils ~80% (highest category 4 & 5) 40
Maturity profile actively managed and well balanced Long-term financing secured Liquidity and maturity profile as per March 2019 Diversified financing sources [€ m] − Bonds & private placements 1500 − Syndicated credit facility 1000 Bond Bond Hybrid Bond Bond Hybrid 2021 2022 1st call* 2025 2026 2076* 0.250% 2.625% 4.50% 1.125% 1.00% 4.50% Average interest rate of financial 500 Cash & cash Private placement liabilities ~2% equivalents 3.95% (2027) 0 Private Next bond maturity in 2021 placement 3.50% (2022) -500 All group financing executed -1000 without financial covenants Financial Syndicated revolving credit -1500 assets facility €1.25 bn -2000 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028+ Financial liabilities Cash & cash equivalents Financial assets Credit facility * Hybrid bond with contractual maturity date in 2076 has a first optional call date in 2023. 41
Climate protection: Target of specific CO2 emissions (scope 1+2)1 of -25% by 2025 Greenhouse gas emissions (Scope 1) on track for 2025 targets 2018 development [t CO2e/t of product] ARLANXEO divestment and linked changes to portfolio led to higher -44% -17% (target: -10%2) Target: -25% specific Scope 1 emissions (generation and use in ongoing operations comparatively more energy 0.55 from primary energy sources) Chemtura akquisition (2018 FY full 0.40 contribution) with impact on scope 1 0.32 0.30 0.30 emissions whereas positive on scope 0.29 0.29 0.29 0.25 0.26 0.25 0.27 2+3 0.19 Mitigating effect from reduced use of coal (China) and higher use of biomass (India & Brazil) … 2007–2010 2011–2015 2016–2025 1 Reduction of specific CO emission (scope 1) by 25% until 2025; reduction of specific energy consumptions (scope 2) by 25% until 2025; Reduction of volatile organic 2 42 compounds (NMVOC3, scope 3) emissions by 25% until 2025; 2 Reduction of specific greenhouse gas emissions (scope 1) by 10% per reporting segment achieved
Awards in ratings and indices reflect high sustainability standards Commitment and entitlement Awards in ratings and indices Member DJSI World and Europe EcoVadis „Gold Recognition Level“ Klimascore A- Index Member 43
LANXESS products enable sustainable solutions in key areas of application Quality you can drink Lightweight solutions Protection against diseases With its Lewabrane® membrane High-performance plastics from Saltidin® is an insect repellent elements and Lewatit® ion exchange LANXESS, such as Durethan®, proprietary to LANXESS subsidiary resins, the Liquid Purification Pocan® and Tepex®, can replace Saltigo. It is used in insect repellents Technologies business unit offers a many of the metal parts in cars to help and lowers the risk of contracting high-performance solution for ensuring reduce weight and fuel consumption, malaria, dengue fever, Zika virus, a reliable supply of drinking and without compromising on vehicle borreliosis or encephalitis. purified water. safety. 44
…and LANXESS keeps innovating to meet present and future sustainability demands ULP membranes Components for e-scooters Circular leather production LANXESS’ new ultra-low pressure Pocan AF 4110 enables light housing With the X-Biomer INSITU technology, (ULP) membranes have the ability to components for bike and scooter retanning agents can be produced remove trace elements originating for batteries and combines low warpage from by-products on site in the tannery. instance from drugs, chemicals, with excellent mechanical properties – This means less chemical use, less cosmetic products and crop protection only one example of the wide-ranging logistics costs, less waste and less agents almost entirely even at low product portfolio for electric mobility. CO2 emissions. operating pressures. 45
Adding value to business and society – various concepts to asses and measure our impacts Societal Added Value Sustainability profile and The quantified impact of our Our contribution to the Agenda societal impacts of our gate-to-gate business 2030 goals to overcome society products operations on society challenges Sustainable Development Goals Product Portfolio Assessment Impact Valuation Concept Analysis 46
Management compensation Fixed annual base salary Fix Annual base salary Compensation in kind (mainly tax value of perquisites) Based on: Targets for EBITDA pre exceptionals Annual Performance Cap: 200% of individual budget Payment (APP) Deduction in case of serious safety and/or environmental problems Long-term orientation Long-Term Based on: Individual APP target for 2 successive fiscal years Performance Bonus Variable (LTPB) Cap: 45% of annual base salary (Ø APP target attainment of 100%) Based on: LXS stock performance vs. MSCI World Chemicals Index* Cap: 30% of annual base salary Long-Term Vesting period: 4 years** Stock Performance Plan (LTSP)* Until 2017: Personal investment in LXS shares (5% of annual base salary) Since 2018: Share performance rights plus share ownership guidelines (investment in LXS shares: CEO 1.5x and board members 1x of base salary) *LTSP 2014–2017; Dow Jones STOXX 600 ChemicalsSM serves as a reference index for the LTSP 2010–2013 ** Five year vesting period applies to LTSP 2010–2013 47
Slightly higher exceptional items (on EBIT) due to plant closure in Jinshan and projects [€ m] Q1 2018 Q1 2019 FY 2018 FY 2019 Thereof Thereof Thereof Thereof Excep. Excep. Excep. Excep. D&A D&A D&A D&A Advanced Intermediates 0 0 0 0 0 0 0 0 Specialty Additives 0 0 1 0 0 0 1 0 Performance Chemicals 1 0 4 0 1 0 4 0 Engineering Materials 0 0 0 0 0 0 0 0 Reconciliation 14 0 17 0 14 0 17 0 Total 15 0 22 0 15 0 22 0 48
Upcoming events 2019 / 2020 Proactive capital market communication mBank Chemicals Day June 4 Warsaw dbAccess Berlin Conference June 5/6 Berlin Exane BNP Paribas 21st CEO Conference June 11/12 Paris J.P. Morgan Cazenove European Materials Conference June 12 London Morgan Stanley Cannon Ball Run June 25 Cologne Q2 2019 results August 2 Goldman Sachs & Berenberg German Corporate Conference September 23-25 Munich Q3 2019 results November 13 Meeting the Management November 15 Cologne Annual Stockholders’ Meeting 2020 May 13 Cologne 49
Contact details Investor Relations Oliver Stratmann Katharina Forster Head of Treasury & Investor Relations Institutional Investors / Analysts / AGM Tel.: +49-221 8885 9611 Tel.: +49-221 8885 1035 Fax.: +49-221 8885 5400 Mobile: +49-151 7461 2789 Mobile: +49-175 30 49611 Email: Katharina.Forster@lanxess.com Email: Oliver.Stratmann@lanxess.com André Simon Eva Frerker Institutional Investors / Analysts Head of Investor Relations Tel.: +49-221 8885 3494 Tel.: +49-221 8885 5249 Mobile: +49-175 30 23494 Mobile: +49 151 74612789 Email: Andre.Simon@lanxess.com Email: Eva.Frerker@lanxess.com Janna Günther Laura Stankowski Private Investors / AGM Assistant to André Simon Tel.: +49-221 8885 3262 Fax.: +49-221 8885 4944 Tel.: +49-221 8885 1989 Email: Laura.Stankowski@lanxess.com Mobile: +49 151 7461 2615 Email: Janna.Guenther@lanxess.com Jens Ussler Institutional Investors / Analysts Tel.: +49-221 8885 7344 Visit the IR Mobile: +49 151 74612913 Email: Jens.Ussler@lanxess.com website 50
Abbreviations Advanced Intermediates Performance Chemicals AII Advanced Industrial Intermediates IPG Inorganic Pigments SGO Saltigo LEA Leather MPP Material Protection Products LPT Liquid Purification Technologies Specialty Additives Engineering Materials LAB Lubricant Additives Business HPM High Performance Materials PLA Polymer Additives URE Urethane Systems RCH Rhein Chemie 51
You can also read